Novorapid and Hypokalaemic syndrome - from FDA reports

Hypokalaemic syndrome is found among people who take Novorapid, especially for people who are female, 60+ old , have been taking the drug for < 1 month, also take medication Lantus, and have Type 2 diabetes. This study is created by eHealthMe based on reports of 12,907 people who have side effects when taking Novorapid from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).

On Oct, 18, 2018

12,907 people reported to have side effects when taking Novorapid.
Among them, 110 people (0.85%) have Hypokalaemic syndrome

Number of reports submitted per year:

Could Novorapid cause Hypokalaemic syndrome?

Time on Novorapid when people have Hypokalaemic syndrome *:

Gender of people who have Hypokalaemic syndrome when taking Novorapid *:

  • female: 56.88 %
  • male: 43.12 %

Age of people who have Hypokalaemic syndrome when taking Novorapid *:

Top conditions involved for these people *:

  1. High Blood Pressure: 17 people, 15.45%
  2. Type 2 Diabetes: 17 people, 15.45%
  3. Preventive Health Care: 8 people, 7.27%
  4. Pain: 8 people, 7.27%
  5. Oedema (fluid collection in tissue): 7 people, 6.36%

Click here to view more results or personalize the results to your gender and age

Top co-used drugs for these people *:

  1. Lantus: 34 people, 30.91%
  2. Levemir: 19 people, 17.27%
  3. Slow-K: 15 people, 13.64%
  4. Aldactone: 14 people, 12.73%
  5. Lasix: 13 people, 11.82%

Click here to view more results or personalize the results to your gender and age

Top other side effects for these people *:

  1. Hypoglycemia (low blood sugar): 24 people, 21.82%
  2. Diarrhea: 10 people, 9.09%
  3. Anaemia (lack of blood): 10 people, 9.09%
  4. Malaise (a feeling of general discomfort or uneasiness): 10 people, 9.09%
  5. Breathing Difficulty: 8 people, 7.27%

Click here to view more results or personalize the results to your gender and age

* Approximation only. Some reports may have incomplete information.

FDA reports used in this study

Do you have Hypokalaemic syndrome while taking Novorapid?

You are not alone:

Related studies


Novorapid has active ingredients of insulin aspart recombinant. It is often used in type 1 diabetes. (latest outcomes from Novorapid 13,003 users)

Hypokalaemic syndrome

Hypokalaemic syndrome (serum concentration of potassium <3.5) has been reported by people with high blood pressure, osteoporosis, pain, depression, multiple myeloma (latest reports from 41,422 Hypokalaemic syndrome patients).

Drugs that are associated with Hypokalaemic syndrome
Hypokalaemic syndrome (2,490 drugs)
Could your condition cause Hypokalaemic syndrome
Hypokalaemic syndrome (2,335 conditions)
Novorapid side effects
Browse all side effects of Novorapid
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Novorapid and have Hypokalaemic syndrome

Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.